241 related articles for article (PubMed ID: 33059994)
1. Bleomycin sclerotherapy in lymphangiomas of the head and neck region: a prospective study.
Tiwari P; Pandey V; Bera RN; Sharma SP; Chauhan N
Int J Oral Maxillofac Surg; 2021 May; 50(5):619-626. PubMed ID: 33059994
[TBL] [Abstract][Full Text] [Related]
2. Efficacy Of Intralesional Bleomycin Injection Sclerotherapy In Macrocystic Lymphangioma In Paediatric Patients.
Muhammad Khuzaemah Saalim Hashmi SA; Hussain M; Ahmad S; Gillani K
J Ayub Med Coll Abbottabad; 2020; 32(1):42-45. PubMed ID: 32468753
[TBL] [Abstract][Full Text] [Related]
3. Bleomycin A5 sclerotherapy for cervicofacial lymphatic malformations.
Yang Y; Sun M; Ma Q; Cheng X; Ao J; Tian L; Wang L; Lei D
J Vasc Surg; 2011 Jan; 53(1):150-5. PubMed ID: 20843632
[TBL] [Abstract][Full Text] [Related]
4. Percutaneous ultrasound-guided sclerotherapy with polidocanol microfoam for lymphatic malformations.
Yamaki T; Sasaki Y; Hasegawa Y; Osada A; Konoeda H; Hamahata A; Nozaki M; Sakurai H
J Vasc Surg Venous Lymphat Disord; 2017 Sep; 5(5):707-714. PubMed ID: 28818226
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of doxycycline and sodium tetradecyl sulfate sclerotherapy in pediatric head and neck lymphatic malformations.
Farnoosh S; Don D; Koempel J; Panossian A; Anselmo D; Stanley P
Int J Pediatr Otorhinolaryngol; 2015 Jun; 79(6):883-887. PubMed ID: 25887132
[TBL] [Abstract][Full Text] [Related]
6. [Management of lymphatic malformations in oral and maxillofacial regions: the rationale according to the new classification].
Zheng JW; Qin ZP; Zhang ZY
Shanghai Kou Qiang Yi Xue; 2005 Dec; 14(6):553-6. PubMed ID: 16400476
[TBL] [Abstract][Full Text] [Related]
7. Lymphatic malformations in children: treatment outcomes of sclerotherapy in a large cohort.
Bouwman FCM; Kooijman SS; Verhoeven BH; Schultze Kool LJ; van der Vleuten CJM; Botden SMBI; de Blaauw I
Eur J Pediatr; 2021 Mar; 180(3):959-966. PubMed ID: 33051716
[TBL] [Abstract][Full Text] [Related]
8. Sclerotherapy of lymphangiomas of the head and neck.
Wiegand S; Eivazi B; Zimmermann AP; Sesterhenn AM; Werner JA
Head Neck; 2011 Nov; 33(11):1649-55. PubMed ID: 20737487
[TBL] [Abstract][Full Text] [Related]
9. Management of cervicofacial lymphatic malformations requires a multidisciplinary approach.
Zobel MJ; Nowicki D; Gomez G; Lee J; Howell L; Miller J; Zeinati C; Anselmo DM
J Pediatr Surg; 2021 May; 56(5):1062-1067. PubMed ID: 33982660
[TBL] [Abstract][Full Text] [Related]
10. Macrocystic Lymphangioma in Children Treated by Sclerotherapy With Bleomycin.
Sonmez K; Karabulut R; Turkyilmaz Z
J Craniofac Surg; 2020; 31(3):e250-e251. PubMed ID: 31977688
[TBL] [Abstract][Full Text] [Related]
11. Treatment of lymphangioma in children: our experience of 128 cases.
Okazaki T; Iwatani S; Yanai T; Kobayashi H; Kato Y; Marusasa T; Lane GJ; Yamataka A
J Pediatr Surg; 2007 Feb; 42(2):386-9. PubMed ID: 17270554
[TBL] [Abstract][Full Text] [Related]
12. Percutaneous sclerotherapy of massive macrocystic lymphatic malformations of the face and neck using fibrin glue with OK-432 and bleomycin.
Chen WL; Huang ZQ; Chai Q; Zhang DM; Wang YY; Wang HJ; Wang L; Fan S
Int J Oral Maxillofac Surg; 2011 Jun; 40(6):572-6. PubMed ID: 21367582
[TBL] [Abstract][Full Text] [Related]
13. Safety and Efficacy of Bleomycin Slow Infusion Sclerotherapy Using a Syringe Pump for Microcystic and Mixed Lymphatic Malformations.
Cha JG; Lee J; Lee SY; Chung HY; Lee SJ; Huh S; Kim JY; Hong J
Cardiovasc Intervent Radiol; 2022 Sep; 45(9):1288-1294. PubMed ID: 35864208
[TBL] [Abstract][Full Text] [Related]
14. Intralesional bleomycin sclerotherapy in childhood lymphangioma.
Erikçi V; Hoşgör M; Yıldız M; Örnek Y; Aksoy N; Okur Ö; Demircan Y; Genişol İ
Turk J Pediatr; 2013; 55(4):396-400. PubMed ID: 24292033
[TBL] [Abstract][Full Text] [Related]
15. Sclerotherapy for lymphangioma in children.
Sanlialp I; Karnak I; Tanyel FC; Senocak ME; Büyükpamukçu N
Int J Pediatr Otorhinolaryngol; 2003 Jul; 67(7):795-800. PubMed ID: 12791456
[TBL] [Abstract][Full Text] [Related]
16. Alcoholic solution of zein (Ethibloc) sclerotherapy for treatment of lymphangiomas in children.
Emran MA; Dubois J; Laberge L; Al-Jazaeri A; Bütter A; Yazbeck S
J Pediatr Surg; 2006 May; 41(5):975-9. PubMed ID: 16677896
[TBL] [Abstract][Full Text] [Related]
17. Intralesional Bleomycin for Orbital Lymphatic Malformations: Comparison of Clinical Versus Radiologic Regression by Volumetric Analysis.
Dave TV; Madhuri BK; Kaliki S
Ophthalmic Plast Reconstr Surg; 2021 May-Jun 01; 37(3S):S85-S91. PubMed ID: 32976330
[TBL] [Abstract][Full Text] [Related]
18. Lymphangioma circumscriptum treated with combination of Bleomycin sclerotherapy and Radiofrequency ablation.
Khurana A; Gupta A; Ahuja A; Sardana K; Malhotra P
J Cosmet Laser Ther; 2018 Oct; 20(6):326-329. PubMed ID: 29979907
[TBL] [Abstract][Full Text] [Related]
19. Bleomycin sclerotherapy for large diffuse microcystic lymphatic malformations.
Sheng L; Yu Z; Li S; Cao W; Jiang Z
Gland Surg; 2021 Jun; 10(6):1865-1873. PubMed ID: 34268071
[TBL] [Abstract][Full Text] [Related]
20. Safety and efficacy of bleomycin sclerotherapy for microcystic lymphatic malformation.
Chaudry G; Guevara CJ; Rialon KL; Kerr C; Mulliken JB; Greene AK; Fishman SJ; Boyer D; Alomari AI
Cardiovasc Intervent Radiol; 2014 Dec; 37(6):1476-81. PubMed ID: 24938907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
